4-Chloro-2-methyl-2H -pyrazole-3-carboxylic acid methyl ester, 100mg

(4S,4'S)-4,4'-Di((S)-sec-butyl)-4,4',5,5'-tetrahydro-2,2'-bioxazole, 97%, 250mg

Nicotinic anhydride, 95.0%, 1g

Hexadecylpyridinium Chloride Monohydrate>98.0%(HPLC)(T)25g

1-(1H-PYRAZOLO[3,4-B]PYRIDIN-1-YL)PROPAN-2-ONE, 95.0%, 250mg

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 100, 2000 ml, 250 mm, 1 Piece

6-Amino-5-(2-furoyl)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, 95.0%, 250mg

N-(2-hydroxyethyl)-N-methylacetamide, 95.0%, 2.5g

3-(4-Chlorophenyl)cyclohex-2-en-1-one, 95%, 500mg

2-Chloro-6-nitrobenzaldehyde, 95.0%, 5g

2-(Difluoromethoxy)aniline, 98.0%, 25g

1,3-Bis(methacryloxypropyl)tetrakis-(trimethylsiloxy) disiloxane, 85%, 100g

3-Phenylpropylamine, 98.0%, 5g